different crypto currency- Top Featured snippets

Zhongzhiwei Technology completed tens of millions of yuan financing. On December 12th, Nanjing Zhongzhiwei Information Technology Co., Ltd. (Zhongzhiwei Technology) completed tens of millions of yuan B1 financing, which was jointly invested by Guangzhou Baiyun Financial Holding Group Co., Ltd. and Beijing Hongfeng Private Equity Fund Management Co., Ltd. This round of financing funds will be used for iterative application of AI+ network security products, breakthrough in key industry landing scenarios and market channel construction. Zhongzhiwei Technology is a solution provider of "city-level data+digital security operation", and has launched a series of new platform-based network security products around AISecOps (artificial intelligence security operation).The Nikkei 225 index just broke through the 40000.00 mark, and the latest report was 40000.43, up 1.60% in the day.ECB: Domestic inflation has dropped slightly, but it is still at a high level. ECB: Staff now expect the economic recovery to be slower than predicted in September. As time goes on, the influence of restrictive monetary policy gradually fades, which should support the recovery of domestic demand. Domestic inflation has declined slightly, but it is still at a high level, mainly because wages and prices in some industries are still being adjusted to adapt to the past inflation surge.

New Cape: At present, the company's revenue from AI products is not high. The new Cape said on the interactive platform on December 12 that the company actively explored in the field of artificial intelligence and gradually established its own AI corpus to support the research and development of intelligent services and products. At present, the company's AI product revenue is not high, which will not have a significant impact on the company's performance.Guoxuan Hi-Tech: It plans to invest a total of 2.514 billion euros to build new energy battery production bases in Slovakia and Morocco. Guoxuan Hi-Tech announced that the company plans to invest in Slovakia with its own and self-raised funds to build high-performance lithium batteries and supporting projects with an annual output of 20GWh, with a total investment of no more than 1.234 billion euros. On the same day, it was announced that the company plans to invest in Morocco with its own and self-raised funds to build a high-performance lithium battery and supporting projects with an annual output of 20GWh, with a total investment of no more than 1.28 billion euros.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)

The United States ITC issued a 337-part final ruling on the wireless front-end module and its downstream equipment. According to the China Trade Relief Information Network, on December 10, 2024, the United States International Trade Commission (ITC) issued a notice saying that it made a 337-part final ruling on a specific wireless front-end module and its downstream equipment: the preliminary ruling (No.13) made by the administrative judge in this case on November 8, 2024 will not be reviewed, that is, based on the withdrawal of the applicant, Kangxi Communication Technology (Shanghai) Co., Ltd. and Ruijie Network Co., Ltd. are listed as defendants.The legal representative of Sanzhiyang Culture Media Co., Ltd. changed. Tianyancha App showed that on December 10, Hefei Sanzhiyang Culture Media Co., Ltd. changed its business. Ba Shuai stepped down as the legal representative, executive director and general manager, and Zhang Yong was the legal representative, director and manager. The company was established in May 2022 with a registered capital of RMB 1 million. Its business scope includes radio and television program production and operation, performance brokerage, advertising, organization of cultural and artistic exchange activities, conference and exhibition services, etc. It is wholly owned by Hefei Sanzhiyang Network Technology Co., Ltd.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).